JnJ submits application to USFDA for Subcutaneous amivantamab for patients with EGFR-mutated non-small cell lung cancer Ruchika Sharma19 Jun 2024 3:56 PM ISTRaratin: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration...
Cipla EU to infuse additional EUR 3 million in Ethris Ruchika Sharma19 Jun 2024 2:53 PM ISTMumbai: Cipla Limited has announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3...
USFDA nod to Alembic Pharma stroke and blood clots drug Dabigatran Etexilate Ruchika Sharma19 Jun 2024 12:12 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
USFDA issues 15 observations for Jubilant HollisterStier General Partnership Montreal facility Ruchika Sharma19 Jun 2024 11:15 AM ISTNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded the audit of the...
Takeda announces Phase 3 topline results for Soticlestat in patients with Dravet Syndrome, Lennox-Gastaut Syndrome Ruchika Sharma18 Jun 2024 4:14 PM ISTOsaka: Takeda has announced topline data from its SKYLINE and SKYWAY studies. SKYLINE (TAK-935-3001) was a multicenter, randomized, double-blind...
Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma18 Jun 2024 2:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Lupin ropes in Abdelaziz Toumi as CEO of its API CDMO Subsidiary Ruchika Sharma18 Jun 2024 12:29 PM ISTMumbai: Global pharma major Lupin Limited has announced the appointment of Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly...
USFDA approves Merck Keytruda plus Carboplatin, Paclitaxel for Primary Advanced or Recurrent Endometrial Carcinoma Ruchika Sharma18 Jun 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved...
USFDA approves Alembic Pharma Icatibant Injection for acute attacks of hereditary angioedema Ruchika Sharma17 Jun 2024 3:29 PM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
Himachal CM ensures State financial backing for bulk drug park project alongside Central aid to ensure timely completion Ruchika Sharma17 Jun 2024 2:14 PM ISTHimachal Pradesh: Chief Minister Thakur Sukhvinder Singh Sukhu presided over a high level meeting here to review the progress of the...
AbbVie, FutureGen ink pact to develop Next-Generation Therapy for Inflammatory Bowel Disease Ruchika Sharma17 Jun 2024 12:30 PM ISTNorth Chicago, IlI.: AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. have announced a license agreement to develop FG-M701, a next...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
